Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 2/20 | 0.42 |
| ▸ | CTSV | O60911 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7815730 | 0.96 | NOX4 (0.45) | NOX4POLBHTR6CTSVCTSL | |
| SCHEMBL7969048 | 0.93 | HTR6 (0.43) | NOX4POLBHTR6CTSVCTSL | |
| SCHEMBL7981817 | 0.93 | POLB (0.49) | NOX4POLBHTR6CTSVCTSL | |
| SCHEMBL7981880 | 0.91 | PPARG (0.47) | NOX4POLBHTR6CTSVCTSL | |
| SCHEMBL7969050 | 0.89 | HTR6 (0.47) | NOX4POLBHTR6 | |
| SCHEMBL7982037 | 0.83 | NOX4 (0.39) | NOX4POLBCTSVCTSLPIK3R1 | |
| SCHEMBL7827050 | 0.81 | HTR6 (0.39) | POLBHTR6 | |
| SCHEMBL7811436 | 0.80 | NOX4 (0.49) | NOX4POLBPIK3R1PIK3CA | |
| SCHEMBL7818699 | 0.78 | TP53 (0.52) | HTR6 | |
| SCHEMBL7814384 | 0.78 | HTR6 (0.45) | POLBHTR6PIK3R1PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6180637-B1 | THERAPY FOR PARKINSON, ALZHEIMER DISEASE | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 2001-01-30 | — | — | US | claimed |
| US-6180637-B1 | THERAPY FOR PARKINSON, ALZHEIMER DISEASE | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 2001-01-30 | — | — | US | disclosed |